About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05012202

Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women

Postpartum hemorrhage is a well-known complication of delivery and the leading cause of maternal mortality worldwide. In developed nations, a complete blood count (CBC) is commonly collected as a mean...

Lead sponsor: The University of Texas Medical Branch, Galveston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

The University of Texas Medical Branch, Galveston

This will be a prospective cohort study. The investigators will recruit 41 pregnant women admitted for delivery. Following delivery, a sample of vaginal blood will be collected and the Hemi device will be used to obtain hematocrit. These results will be masked to the clinical team until the time of data collection. A CBC will also be collected via venipuncture at this time. This study will be comparing hematocrit levels by standard clinical laboratory versus results from the device.

Age

18 - 50 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Pregnant women between the ages of 18-50
•Admission for vaginal delivery
•Singleton pregnancy
•Term gestation (\>=37 weeks)

Exclusion Criteria

•Pregnant women \< 18 years or \> 50 years
•Incarcerated patients
•Patient unwilling or unable to provide consent
•Enrolled in another trial that may affect outcome

Related studies

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

NCT07526311 · Myoma;Uterus, Blood Loss

RECRUITINGPhase 2

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT07217899 · Blood Loss, Surgical, Blood Loss, Postoperative, and more

Transfusion Surveillance in Anaesthesia

NCT06403163 · Transfusion Reaction, Transfusion Related Complication, and more

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

NCT06164769 · Tumor of Pancreas, Surgical Blood Loss

Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.

NCT03853434 · Spine Metastasis, Early Goal Directed Therapy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 17, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment41

Start dateOct 2021

Last updatedJul 17, 2023

Condition

Locations shown

UTMB

Galveston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions